Menu

Blog

Oct 11, 2022

FDA Approves AMX0035 (Relyvrio) for ALS

Posted by in category: biotech/medical

😀


The FDA has approved the drug Relyvrio, which was shown in studies to extend the lives of people with ALS by about 6 months.

Comments are closed.